Previous studies have revealed that HOXD9 promoter methylation is higher in tumors than in healthy tissue and that DNA methylation levels correlate with the expression of HOXD9 mRNA and protein in malignant melanoma and glioma [21, 31]. Here, HOXD9 is linked to glioma.